Bristol Eye Hospital is a specialist ophthalmic hospital in Bristol. It is part of the University Hospitals Bristol and Weston NHS Foundation Trust. The University of Bristol Dental Hospital is adjacent, and the Bristol Royal Infirmary is nearby.

During the past decade, Bristol Eye Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 10 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bristol Eye Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "King's College Hospital NHS Trust" with 3 trials sponsored, "Lux Biosciences, Inc." with 3 trials sponsored and "National Eye Institute (NEI)" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bristol Eye Hospital" #1 collaborator was "King's College London" with 2 trials as a collaborator, "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator, "Funded by Fight for Sight" with 1 trials as a collaborator, "NHS Grampian" with 1 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Bristol Eye Hospital" are "Diabetic Retinopathy" (6 trials), "Geographic Atrophy" (6 trials), "Diabetic Macular Edema" (5 trials), "Macular Degeneration" (4 trials) and "Panuveitis" (3 trials). Many other conditions were trialed in "Bristol Eye Hospital" in a lesser frequency.

Most popular intervention types in "Bristol Eye Hospital" are "Drug" (27 trials), "Other" (9 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ranibizumab" (4 trials), "Sham Procedure" (4 trials), "Bevacizumab" (3 trials) and "LX211" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bristol Eye Hospital" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Bristol Eye Hospital". 1 are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Bristol Eye Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Bristol Eye Hospital, 9 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".